Drug-loaded nanoparticles are tiny particles, typically measuring between 10 and 1000 nanometers, that can be used to deliver therapeutic drugs and other therapeutic agents to target tissues. These particles are typically made of polymeric materials, such as polylactic-co-glycolic acid (PLGA), and are often surface-modified with ligands or targeting agents to improve their ability to target specific tissues or cells. Drug-loaded nanoparticles can be engineered to release their payloads over an extended period of time, making them useful for sustained drug delivery. They can also be designed to protect the drug from degradation in the body, allowing for increased bioavailability. Nanoparticles have been used to deliver a variety of drugs, including chemotherapeutic agents, proteins, peptides, nucleic acids, and even live cells. The use of drug-loaded nanoparticles has enabled researchers to develop novel targeted drug delivery strategies that can improve therapeutic efficacy while reducing unwanted side effects.
Title : 40,000 implants in humans and no failure: The impact of nanomedicine
Thomas J Webster, Hebei University of Technology, China
Title : Cellulose-derived biochar modified with iron oxide and ZnO nanoparticles by a novel one-step pyrolytic method for removal of emerging contaminants from water
Rashad Al Gaashani, Hamad Bin Khalifa University, Qatar
Title : Harnessing the unique properties of engineered nanostructures for sensing
Harry Ruda, University of Toronto, Canada
Title : Circumventing challenges in developing CVD graphene on steels for extraordinary and durable corrosion resistance
Raman Singh, Monash University, Australia
Title : Nano DAP augments productivity, phosphorus use efficiency, and profitability of spring wheat in India
Binaya Kumar Parida, Coromandel International Ltd, India
Title : Lipid nanoparticles formulations: From bench scale to industrial scale
Mohammad A Obeid, RAK Medical and Health Sciences University, United Arab Emirates